A double–blind crossover comparison study of the safety and efficacy of mebeverine with mebeverine sustained release in the treatment of irritable bowel syndrome-Reference-Cited by-同舟云学术

A double–blind crossover comparison study of the safety and efficacy of mebeverine with mebeverine sustained release in the treatment of irritable bowel syndrome

Published:1995-10 Issue:5 Volume:20 Page:277-282
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Outryve M.,Mayeur S.,Meeus M. A.,Rosillon D.,Hendrickx B.,Ceuppens M.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2710.1995.tb00663.x/fullpdf

Reference15 articles.

1. Functional bowel disorders in apparently healthy people

2. Bowel Patterns Among Subjects Not Seeking g Health Care

3. Comparison of various treatments for irritable bowel syndrome.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The place of antispasmodic drugs in modern therapy of irritable bowel syndrome;Meditsinskiy sovet = Medical Council;2023-05-25

2. The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome—A Systematic Review;Journal of Clinical Medicine;2022-02-17

3. IBS-like manifestations in large intestine diverticular disease;Medical Council;2019-05-12

4. Effect of antispasmodic agents for the treatment of irritable bowel syndrome;Journal of the Korean Medical Association;2018

5. HPLC–MS/MS method for the simultaneous quantification of desmethylmebeverine acid, mebeverine acid and mebeverine alcohol in human plasma along with its application to a pharmacokinetics study;Journal of Pharmaceutical and Biomedical Analysis;2017-05